Program

MetaCardis conference 2018 – Program

Mind your gut microbiota for your metabolism and heart ! – a Metacardis international event  September 28th and 29th, 2018

Friday, September 28th, 2018

Meeting registration (8.30h-10.30h)

9:00    Welcome address and introduction
Karine Clément: The Metacardis project

9:30    MetaCardis Keynote Speaker  (Chair: Karine Clement)
Prof Dusko Ehrlich, INRA: Prof Dusko Ehrlich, INRA: The history of metagenomics

10:30    Coffee Break

10:45    Diabetes and Obesity I (Chair: Fredrik Bäckhed)
Principal investigators (25’ presentation, 5’ discussion)
Fredrik Bäckhed:  Fredrik Bäckhed: Translational approaches to delineate the role of microbiome in metabolic diseases
Max Nieuwdorp:   Max Nieuwdorp: Using FMT to dissect the causality of gut microbiota in human metabolic disease

Unpublished results from young investigators (15’)
Karen Assmann: Karen Assmann: Immune cells and gut metagenomics
Gwen Falony:  Gwen Falony: Quantitative profiling of the gut microbiota – impacts for clinical research

12:30    LUNCH break

13:30    Diabetes and Obesity II (Chair: Judith Aron-Wisnewsky )
Principal investigators (25’ presentation, 5’ discussion)
Hervé Blottière:  Hervé Blottière: Commensal bacteria and the intestine
Eugeni Belda: Eugeni Belda: Integrative study of host and microbiome metabolic profiles in the transition to severe obesity and impaired metabolic health

Results from the MetaCardis MetaTransition
Unpublished results from young investigators (15’):
Judith Aron-Wisnewsky: Judith Aron-Wisnewsky: Bariatric surgery and metagenomics
Francois Brial:  Francois Brial: Microbial metabolites in rodent models of insulin resistance

15:15    Coffee Break

15:30    Cardiovascular diseases (Chair: Oluf Pedersen)
Principal investigators (25’ presentation, 5’ discussion)
Oluf Pedersen:  Oluf Pedersen:  Regulators of the human microbiome
Kristiansen K.: Kristiansen K.: The Microbiome and atherosclerosis.
Unpublished results from young investigators (15’)
Sebastien Fromentin:  Sebastien Fromentin: Microbiome and metabolome features of human ischaemic heart disease deconvoluted for impact of medication and co-morbidities’

17:15    Focus on Big Data (Chair: Jean-Daniel Zucker)
Adrien Basdevant: Adrien Basdevant: Legal and ethical issues of big data

Thierry Magnins & Mathieu Guillermin             Thierry Magnins & Mathieu Guillermin: Ethics embedded in MetaCardis

18:15    Evening event: Poster session with cocktail

Saturday, September 29th, 2018

9:00    Drug-related effects (Chair Rima Chakaroun)
Principal investigators (25’ presentation, 5’ discussion)
Peer Bork: Peer Bork: Importance of drugs in metagenomic profiles
Valentina Tremaroli: Valentina Tremaroli: Metformin and diabetes

Unpublished results from young investigators (15’)
Sofia Forslund: Sofia Forslund: Elucidating drug effects on the microbiota

10:40  Coffee Break

10:45  NAFLD/NASH (Chair: Jeroen Raes)
Principal investigators (25’ presentation, 5’ discussion)
  Philippe Gérard: Philippe Gérard: Gut microbiota and liver disease: lessons from germ-free animal models
  Marc Dumas: Marc Dumas: Molecular Phenomics and Metagenomics of Hepatic Steatosis in Non-Diabetic Obese Women
Unpublished results from young investigators (15’)
Chloe Vigliotti:  Chloe Vigliotti: Metagenomic biomarkers associated with NASH and fibrosis progression

12:15  The future of the gut microbiota in CMDs (Chair: Karine Clément)
Eran Elinav: Eran Elinav: Future of metagenomics in metabolic diseases

13:15   Conference closing remarks by Karine Clément

13:30   Finger Lunch

Please note: last minute modifications might be necessary.